Traferox Technologies Inc

$424,050.00 CAD

≈ 5 Canadians' average pay for a year
Department
National Research Council Canada
Program
Industrial Research Assistance Program – Contributions to Firms
Recipient country
Canada
Fiscal year
2023-2024
Agreement period
June 5, 2023 – August 31, 2024
Reference
nrc-cnrc:172-2023-2024-Q1-1006748

Published purpose

Traferox will design, manufacture, and validate systems that can perform normothermic ex vivo perfusion of the liver and the heart. In normothermic ex vivo organ perfusion, solid organs are perfused with a solution containing red blood cells and maintained at body temperature. Normothermic ex vivo organ perfusion enables detailed functional assessment of the organ and assessment of their suitability for transplant. This project will create systems suitable for preclinical research.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported August 3, 2026 from open.canada.ca Grants & Contributions